Evidence map›Paper›PMID 42673143›Full record

Trial reportEuropean stroke journal2026

Determinants of procedural sedation requirements during endovascular treatment for acute anterior circulation ischaemic stroke: a post-hoc analysis of the INDIVIDUATE trial.

Min Chen, David Batra, Nina Bieber, Lukas D Sauer, Arne Potreck, Markus Möhlenbruch, Peter Ringleb, Silvia Schönenberger

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European stroke journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04578288 (Individualized Blood Pressure Management During Endovascular Treatment of Acute Ischemic Stroke Under Procedural Sedation), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04578288 nacompletednot on this map

Individualized Blood Pressure Management During Endovascular Treatment of Acute Ischemic Stroke Under Procedural Sedation

TypeinterventionalSponsorUniversity Hospital HeidelbergRan2020 to 2022Enrolled250ConditionsAcute Ischemic StrokeArmsINDIVIDUALIZED BLOOD PRESSURE MANAGEMENT DURING ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE UNDER PROCEDURAL SEDATION
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Min ChenDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-9079-9298
David BatraDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Nina BieberDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Lukas D SauerInstitute of Medical Biometry, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-1340-9994
Arne PotreckDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Markus MöhlenbruchDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-5075-704X
Peter RinglebDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Silvia SchönenbergerDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-3348-6719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProcedural sedation during EVT for acute ischaemic stroke is widely used, but factors associated with analgosedative drug requirements remain poorly characterised. We aimed to identify patient and procedural factors associated with analgosedative drug requirements during EVT and explore their association with clinical outcomes. PATIENTS AND

methodsWe performed a post hoc analysis of the randomised INDIVIDUATE trial, including patients with anterior circulation ischaemic stroke undergoing EVT under procedural sedation. Sedation exposure was quantified using mean propofol, remifentanil and esketamine dose rates derived from protocolised 5-min medication records. Multivariable linear regression analyses were used to identify factors associated with sedation requirements. Sensitivity analyses were performed using body weight-normalised dose rates in patients with available body weight data. Exploratory analyses assessed associations between sedation requirements and procedural and clinical outcomes.

resultsOf 250 patients enrolled in the INDIVIDUATE trial, 239 were included. In multivariable analyses, male sex was associated with higher propofol and esketamine dose rates; however, after body weight-normalisation, the association with propofol was no longer statistically significant. In weight-normalised sensitivity analyses including 198 patients (82.8%), male sex, ICA + M2 occlusion compared with M1 occlusion and pre-stroke disability remained associated with higher weight-normalised esketamine dose rates (β = 2.39 μg/kg/min, P = .021; β = 13.56 μg/kg/min, P < .001; and β = 2.82 μg/kg/min, P = .028, respectively). Additionally, the number of thrombectomy attempts was associated with higher remifentanil dose rates (β = 0.56 ng/kg/min, P = .010). Higher body weight-normalised esketamine dose rates were associated with less favourable NIHSS change at 24 h (β = 0.17, P = .022). Sedation requirements were not associated with 3-month functional outcome or mortality.

conclusionSedation requirements during EVT appeared to vary according to patient- and procedure-related factors, including sex, occlusion pattern, pre-stroke disability and procedural complexity. Sedation intensity was not associated with long-term clinical outcomes, supporting the use of adequate procedural sedation when clinically indicated. CLINICAL

trial registrationClinicaltrials.gov; NCT04578288.

Indexed as

Brain IschemiaEndovascular ProceduresHypnotics and SedativesIschemic StrokeProcedural SedationStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedPropofolRemifentanilTreatment OutcomeHypnotics and SedativesPropofolRemifentanilacute ischaemic strokeanalgosedationEVT

Identifiers

PMID42673143
PMCPMC13528861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.